Hodgkin lymphoma
Conditions
Interventions
This is a prospective, non-randomized clinical trial without a control group, approved by the Research Ethics Committee of Barretos Cancer Hospital (CAAE No. 94365225.1.0000.5437). The sample size was
20), hemodynamic or respiratory instability, or those transferred to the intensive care unit (ICU) or emergency department during data collection will be excluded. The intervention will be performed u
Sponsors
Fundação Pio XII - Hospital de Câncer de Barretos
Fundação Pio XII - Hospital de Câncer de Barretos
Eligibility
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Adults aged 18 years or older; both sexes; signed informed consent form; diagnosis of an oncohematological disease; undergoing their first hematopoietic stem cell transplantation; thrombocytopenia with a platelet count less than or equal to 50.000/mm³; eligibility for virtual reality use according to the Simulator Sickness Questionnaire with a score less than or equal to 20
Exclusion criteria
Exclusion criteria: Diagnosis of multiple myeloma associated with the risk or presence of pathological fractures; contraindication to virtual reality use according to the Simulator Sickness Questionnaire with a score greater than 20; hemodynamic instability; respiratory instability; transfer to the intensive care unit during the data collection period; transfer to the emergency department during the data collection period
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The use of virtual reality as a physiotherapeutic intervention in oncohematological patients with thrombocytopenia after HSCT is expected to improve functional performance, even under clinically vulnerable conditions. Functional performance will be assessed through motor performance during virtual reality sessions, considering game-related indicators such as the number of balls hit in each session and progression throughout the interventions. | — |
Secondary
| Measure | Time frame |
|---|---|
| The intervention is expected to contribute to the reduction of symptoms such as fatigue, anxiety, and depression, assessed respectively by the Fatigue Assessment Scale (FAS) and the Hospital Anxiety and Depression Scale (HADS).;It is expected to demonstrate the feasibility and safety of the intervention in the hospital setting through the monitoring of vital signs (heart rate, blood pressure, and peripheral oxygen saturation), subjective perception of exertion assessed using the Borg Rating of Perceived Exertion Scale, the occurrence of adverse events, tolerability of virtual reality use, and adherence to physiotherapy sessions, even among patients with a platelet count of less than or equal to 50,000/mm³. | — |
Countries
BR
Contacts
Public ContactLeonardo Barato
Fundação Pio XII - Hospital de Câncer de Barretos
Outcome results
None listed